-
Online Location
UCSF Pride Hall - Room 1950 + Zoom
Integrating clinical and microbial markers to predict tailored drug response in individuals with type 2 diabetes
Chinmay Dwibedi is a group leader at the Swedish node of Nordic-EMBL partnership for Molecular Medicine [MIMS], within the department of Clinical Microbiology, faculty of Medicine at Umeå University, Sweden. He is also a Data-driven Life Sciences [DDLS] fellow in Biology of Infection. His research is focused on studying the human gut microbiota in the context of health and disease.